中国经济网北京1月6日讯 江苏太平洋石英股份有限公司（证券代码：603688，证券简称：石英股 份）昨晚发布关于商业秘密维权暨收到刑事判决书的公告。 三、被告单位连云港强邦石英制品有限公司犯侵犯商业秘密罪，判处罚金人民币二百七十万元。 （罚金于本判决生效之日起十日内缴纳。） 四、被告人段某某犯侵犯商业秘密罪，判处有期徒刑二年，缓期执行三年，并处罚金人民币二十万 元。（缓刑考验期限，从判决确定之日起算。段某某已向本院预缴罚金人民币二十万元。） 五、依法追缴被告人王某某的违法所得人民币二十八万六千六百二十二元三角一分，被告人纪某某 的违法所得人民币三十六万一千八百八十二元八角二分，被告单位连云港强邦石英制品有限公司的违法 所得人民币二百六十五万一千八百六十五元（该款扣押于江苏省连云港市中级人民法院），并上缴国 库。 石英股份表示，刑事判决书仅为一审判决，目前判决尚未生效，案件最终判决及后续执行结果尚存 在不确定性，公司及强邦公司目前经营情况一切正常，上述判决结果对公司本期利润和期后利润不存在 重大不利影响。 2022年1月，公司受让段井强、段井邦持有的强邦公司51%股权，强邦公司自此成为公司控股子公 司。本案中公 ...

石英股份在公告中特别强调，公司为本案被害单位，目前经营情况一切正常，且该判决为一审判决尚未 生效，案件最终结果存在不确定性。待判决生效后，公司将依据此前签订的《股权转让协议》相关条 款，向段井强、段井邦及强邦公司追究民事责任。 天眼查显示，江苏太平洋石英股份有限公司(曾用名：东海县太平洋石英制品有限公司)，成立于1999 年，位于江苏省连云港市，是一家以从事非金属矿物制品业为主的企业，于2014年完成了IPO上市。 石英股份主要从事高纯石英砂、高纯石英管(棒、板、锭、筒)、石英坩埚及其他石英材料的研发、生产 与销售，产品主要应用于半导体、光伏、光纤、光电等领域。之前收购强邦石英，中泰证券（600918） 曾指出是为扩大高纯石英砂生产规模优势，但却因标的历史遗留的商业秘密侵权问题陷入法律纠纷。 财务数据方面，受产品价格下跌影响，石英股份短期业绩承压，2025年前三季度营收、净利分别为7.53 亿元、1.35亿元，同比分别下降24.46%、56.81%。 1月5日，江苏太平洋石英股份（603688）有限公司(简称石英股份)公告称，公司及控股子公司连云港强 邦石英制品有限公司(简称强邦公司)收到江苏省连云港市中级人 ...

（文章来源：每日经济新闻） 1月5日，深圳市灵明光子科技有限公司（简称"灵明光子"）发表声明，公司于2025年12月31日已正式起 诉深圳市速腾聚创科技有限公司（简称"速腾聚创"）经营秘密及技术秘密的行为，向深圳市中级人民法 院提起商业秘密侵权诉讼，该案已被立案受理。灵明光子称，所有产品均系完全自主研发的成果，不存 在任何侵犯他人知识产权的行为。速腾公司此前针对我司提起的相关诉讼，缺乏实质性证据支持。 ...

Core Viewpoint - The company, Weitongli Electric Co., Ltd., is facing challenges in its IPO process due to legal issues and administrative penalties, despite strong financial growth and a prestigious client list in the renewable energy sector [2][11][19]. Financial Performance - Weitongli's revenue is projected to reach nearly 2.4 billion yuan in 2024, with a net profit of 271 million yuan, showing consistent growth over the past three years [2][5]. - Revenue increased from 1.437 billion yuan in 2022 to 2.39 billion yuan in 2024, while net profit rose from 114 million yuan to 271 million yuan during the same period [5]. - In the first nine months of 2025, revenue surged by 32.73% to 2.212 billion yuan, with net profit growing by 10% to 216 million yuan [5]. - The company leads the industry in revenue from hard and flexible connections, with hard connections revenue rising from 529 million yuan in 2022 to 681 million yuan in 2024 [5]. Client Base - Weitongli serves a prestigious list of clients across various sectors, including Siemens, Schneider Electric, BYD, and BMW, indicating its strong market position [3][5]. Business Segments - The company's revenue from the electric power and electrical segment grew from 554 million yuan in 2022 to 807 million yuan in 2024, but its share of total revenue decreased from 42.43% to 36.04% [7]. - The new energy vehicle segment saw significant growth, with revenue increasing from 344 million yuan in 2022 to 825 million yuan in 2024, becoming the largest revenue source by mid-2025 [7]. Legal and Compliance Issues - Weitongli has received seven administrative penalties over two and a half years, raising concerns about its internal governance and compliance [11][14]. - The company is currently involved in two major lawsuits related to commercial secret infringement, with claims exceeding 1 million yuan [16][19]. Family Ownership Structure - The company is predominantly family-controlled, with the founder holding 56.57% of the shares and the family collectively controlling 85.51% [11][12]. - This concentrated ownership structure has implications for governance and decision-making within the company [11][14]. Cash Flow and Financial Health - The company's accounts receivable reached 1.042 billion yuan, representing nearly 70% of current assets, which may impact cash flow [10][14]. - The cash flow from operating activities has shown volatility, with a net cash flow of -43 million yuan in the latest reporting period [10].

科伦博泰生物-B（HK06990，以下简称"科伦博泰"）与其前核心高管团队的漫长纠纷，在2025年12月16 日随着一纸公告的发布，终于尘埃落定。 这起始于2020年高管离职创业，并在2024年至2025年升级为刑事控告与民事诉讼的"商业秘密侵权"案， 最终以一种影响深远的模式达成和解。 具体来看，苏州宜联生物医药有限公司（以下简称"宜联生物"）由TMALIN平台开发、已授权海外的六 条核心ADC（抗体药物偶联物）管线，包括已获BioNTech、罗氏重金引进的明星产品，其过去与未来 的所有授权收入与销售净利润，都将按比例与原东家科伦博泰分享。 科伦博泰与前员工和解 12月16日晚，科伦博泰公告，公司与宜联生物、薛彤彤、肖亮、蔡家强订立和解协议，以解决此前科伦 博泰向宜联生物方面提起的若干争议。 在起纠纷之前，科伦博泰和薛彤彤等人曾是"一家人"。 公开资料显示，宜联生物CEO（首席执行官）兼董事长薛彤彤，曾任科伦博泰总经理，负责生物药和小 分子产品的研发、商业化以及国内外商务合作；并担任科伦药业的药物研究院副院长，负责ADC、重 组蛋白等创新药研发。 肖亮加入宜联生物前曾担任科伦博泰副总裁，负责生物大分子和对外 ...

01 今年，机器人赛道无疑是最受瞩目的风口之一。 据不完全统计，前11个月已有近30家机器人产业链企业向港交所递交上市申请，包括奥迪威、仙工智 能、卡诺普机器人、凯乐士、珞石机器人、优艾智合等。市场热度在资本层面尤为明显，IT桔子数据显 示，仅今年前8个月，机器人领域一级市场融资额已达386.24亿元，是2024年全年融资额的1.8倍。 然而在这股热潮背后，一个残酷的现实是，大多数机器人企业尚未建立起可持续的盈利模式。 它们究竟面临怎样的困境？近日向港股递交招股书的深圳乐动机器人股份有限公司(下称"乐动机器人") 便是一个观察的样本。 这是一家业内明星公司，投资方中，华业天成、源码资本、新希望集团、共创卓信等一线投资机构均在 列，最受关注的当属阿里CEO吴泳铭的圆璟鼎恒，曾参与乐动机器人2022年1月的C轮融资，持有乐动 机器人1.79%的股权。 在一众机器人公司中，乐动机器人的特色在于以视觉感知技术为核心，即为机器人提供"眼睛"。尽管公 司收入在增长，却"以价换量"，没能摆脱连年亏损的局面。 这家由华中科技大学校友创立的公司，正站在一个机遇与风险并存的十字路口。 "高科技"产品，变成了"薄利多销" 根据招股 ...

Core Viewpoint - The legal dispute between Suoteng Juchuang and Lingming Guangzi over alleged infringement of proprietary SPAD chip technology has garnered significant industry attention, with Suoteng Juchuang seeking legal recourse to protect its technological advancements and market position [1]. Company Overview - Suoteng Juchuang specializes in digital lidar technology, particularly focusing on SPAD (Single-Photon Avalanche Diode) chips, which allow each detection pixel to independently receive single photons and generate digital pulse signals [1]. - The company achieved a breakthrough in 2022 by integrating lidar reception and signal processing into a single chip, becoming the first in the industry to mass-produce self-developed SPAD-SoC technology [2]. - Lingming Guangzi, founded in May 2018 by several PhD graduates from Stanford and Delft University of Technology, also offers SPAD-related products and has a strong focus on SPAD technology with over 80% of its workforce in R&D [2]. Industry Context - The digital lidar produced by Suoteng Juchuang is crucial in the current smart driving hardware landscape, as it eliminates most macro-moving parts through solid-state electronic scanning, making systems more compact and durable [1]. - The demand for such technology is significant in scenarios requiring blind spot detection and other advanced driving features [1].

Core Viewpoint - The recent court ruling regarding the commercial secret infringement case involving Longbai Group's subsidiary, Yunnan Yejin New Titanium Industry Co., Ltd., has significant implications for the company and the titanium dioxide industry as a whole [1][3]. Group 1: Legal Proceedings and Outcomes - The court sentenced three former employees for stealing proprietary technology related to titanium dioxide production, with prison terms ranging from 6 to 7 years and a total fine of 32 million yuan [3][8]. - The technology in question is considered a critical "bottleneck" technology in the titanium dioxide industry, which Longbai Group invested heavily in, totaling 2.717 billion yuan since its introduction in 2007 [4][10]. - The court has initiated civil liability proceedings against responsible parties, with the Yunnan Provincial High People's Court already accepting the case [9]. Group 2: Financial Impact on Longbai Group - Longbai Group reported fluctuations in its financial performance, with net profits of 4.676 billion yuan, 3.419 billion yuan, 3.226 billion yuan, and 2.169 billion yuan from 2021 to 2024 [10]. - For the first three quarters of the current year, the company achieved a revenue of 19.436 billion yuan, a year-on-year decrease of 6.86%, and a net profit of 1.674 billion yuan, down 34.68% year-on-year [10]. - The company has indicated that the criminal ruling has not yet taken effect, and the final judgment and subsequent execution results remain uncertain, potentially affecting current and future profits [10]. Group 3: Market Position - Longbai Group is recognized as a leading enterprise in the titanium dioxide industry, with its main products including titanium dioxide, sponge titanium, zirconium products, and lithium battery materials [10][11]. - As of November 6, the company's stock price was 17.90 yuan per share, with a total market capitalization of 42.7 billion yuan [11].

Core Viewpoint - Shenzhen Jincun Technology Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange, but its financial health raises concerns due to significant cash flow issues and high reliance on external funding [1][6][7]. Financial Performance - The company reported explosive revenue growth, with revenues of 2.096 billion, 2.402 billion, and 3.714 billion yuan from 2022 to 2024, and a revenue of 2.060 billion yuan in the first half of 2025, representing a year-on-year growth of 19.33% [3][4]. - However, the net profit for the same periods was 70.519 million, 74.438 million, and 136 million yuan, with a net profit of 146 million yuan in the first half of 2025, showing only a 1.21% increase year-on-year [3][4]. Cash Flow and Liquidity Issues - The company experienced a cumulative net cash outflow of 1.161 billion yuan from operating activities, significantly exceeding its net profit, indicating serious concerns about its true profitability [6][7]. - As of June 30, 2025, the company had bank loans and other borrowings amounting to 1.381 billion yuan, a staggering increase of 747.59% compared to the end of 2022, highlighting a severe liquidity crisis [6][7]. Inventory and Receivables - Inventory and accounts receivable accounted for 81.20% of current assets as of June 30, 2025, indicating a significant amount of working capital is tied up [6][7]. - The company has been unable to effectively manage its inventory, leading to substantial provisions for inventory impairment, which have impacted its financial performance [7]. Legal Risks - The company is currently involved in a lawsuit filed by Jiangbolong, claiming infringement of trade secrets, with a compensation demand of 132 million yuan. The case is still under appeal [8][9]. Supplier Dependency - Jincun Technology has a significant reliance on a few major suppliers, with the top five suppliers accounting for 75.0% to 80.8% of total procurement during the reporting periods [5].

Core Viewpoint - Longbai Group has filed a lawsuit against former executives and a steel company for the alleged infringement of trade secrets related to titanium dioxide production, seeking compensation of 13 billion yuan [1][2][3]. Group 1: Lawsuit Details - The lawsuit was initiated by Longbai Group's subsidiary, Yunnan Metallurgical New Titanium Industry Co., Ltd., against four defendants, including three individuals and Hebei Yanshan Steel Group [2][3]. - The claimed amount in the lawsuit is 13.105 billion yuan, with demands for the defendants to cease using the trade secrets and destroy related materials [2][3]. - The trade secrets in question pertain to the construction process and production technology of a large-scale chlorination titanium dioxide production line [2][3]. Group 2: Background of Defendants - The defendants, including Liu Jianliang, Jiang Shuan, and Zhao Zequan, held significant leadership and technical positions at Yunnan New Titanium before joining Hebei Yanshan's affiliated company [3][4]. - Liu Jianliang was previously the legal representative and chairman of Yunnan New Titanium, leading a team recognized as an innovative team by the Yunnan Provincial Science and Technology Department in 2018 [4]. Group 3: Related Legal Actions - In May 2023, a subsidiary of Hebei Yanshan also filed a lawsuit against Yunnan New Titanium, claiming non-infringement of intellectual property rights, with a disputed amount of 500,000 yuan [5]. - The current lawsuit has not yet gone to trial, and Longbai Group is unable to assess its impact on current or future profits [5].